A polymorphism in the IL1B gene (rs16944 T/C) is associated with cutaneous leishmaniasis caused by Leishmania guyanensis and plasma cytokine interleukin receptor antagonist.


Journal

Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353

Informations de publication

Date de publication:
11 2019
Historique:
received: 09 08 2018
revised: 10 05 2019
accepted: 22 07 2019
pubmed: 30 7 2019
medline: 9 9 2020
entrez: 30 7 2019
Statut: ppublish

Résumé

Nod-like Receptor Protein3 (NLRP3) inflammasome in macrophages infected with Leishmania sp. enhances the secretion of IL-1β. Excess IL-1β production is linked to disease severity in patients with cutaneous leishmaniasis (CL) caused by L. mexicana. Blockade of the NLRP3 inflammasome in cell cultures from skin biopsies of patients with CL caused by L. braziliensis inhibited the release of IL-1β. We hypothesized that common single nucleotide polymorphisms in the IL1B and in its receptor antagonist IL1RN genes may be predictive of CL caused by L. guyanensis. The SNPs -511T/C (rs16944) and +3954C/T (rs1143634) of the IL1B and IL1RN VNTR (rs2234663) were assessed in 881 patients with CL and 837 healthy controls by PCR-RFLP and direct PCR respectively. Plasma cytokines levels were also assayed. The plasma levels of IL-1β were higher in patients compared to control subjects. In contrast, increased plasma levels of IL-1Ra were observed in controls. The rs16944 C/C genotype was more common among the patients (OR = 1.5 [95%CI 1.1-2.0]; P = 0.004) and the C allele suggests susceptibility to CL (OR = 1.2 [95%CI 1.1-1.4]; P = 0.003). The rs16944 C/C genotype shows a tendency to correlate with lower levels of the IL-1Ra cytokine. Low levels of IL-1Ra cytokine and rs16944 C/C genotype seem to confer susceptibility to L. guyanensis-infection in the Amazonas.

Identifiants

pubmed: 31357078
pii: S1043-4666(19)30217-0
doi: 10.1016/j.cyto.2019.154788
pii:
doi:

Substances chimiques

IL1B protein, human 0
IL1RN protein, human 0
Interleukin 1 Receptor Antagonist Protein 0
Interleukin-1beta 0

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

154788

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

George Allan Villarouco da Silva (GAV)

Programa de Pós-Graduação em Imunologia Básica e Aplicada-PPGIBA, Universidade Federal do Amazonas, Manaus, Brazil.

Tirza Gabrielle Ramos de Mesquita (TGR)

Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Amazonas, Brazil.

Helia Valeria de Souza Encarnação (HV)

Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Amazonas, Brazil.

José do Espírito Santo Junior (J)

Programa de Pós-Graduação em Imunologia Básica e Aplicada-PPGIBA, Universidade Federal do Amazonas, Manaus, Brazil.

Karolina da Costa Sabino (K)

Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Amazonas, Brazil.

Isaac de Aguiar Neres (I)

Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Amazonas, Brazil.

Salim Assad de Almeida (SA)

Faculdade de Medicina, Universidade de Nilton Lins, Manaus, Amazonas, Brazil.

Mara Lúcia Gomes de Souza (MLG)

Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Amazonas, Brazil.

Sinésio Talhari (S)

Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Amazonas, Brazil; Faculdade de Medicina, Universidade de Nilton Lins, Manaus, Amazonas, Brazil.

Rajendranath Ramasawmy (R)

Programa de Pós-Graduação em Imunologia Básica e Aplicada-PPGIBA, Universidade Federal do Amazonas, Manaus, Brazil; Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Amazonas, Brazil; Faculdade de Medicina, Universidade de Nilton Lins, Manaus, Amazonas, Brazil. Electronic address: ramasawm@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH